Patents for C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442) |
---|
01/27/2005 | US20050019386 In mixture of membrane-forming amphiphiles subjected to high pressure homogenization or ultrasound; contain immunomodulator, cyclosporin, and/or at least one cytokine or polyethylene glycol-cytokines |
01/26/2005 | EP1500393A1 Injectable composition containing taxol |
01/26/2005 | CN1571779A Process for the preparation of the 14beta-hydroxy-baccatin III -1, 14-carbonate |
01/26/2005 | CN1186340C C10 carbonate substituted taxanes as antitumor agents |
01/25/2005 | US6846937 Removing acyl groups appended by ester linkage to 2'-hydroxyl group present in paclitaxel-related molecules by treating with alcohol under non-acidic conditions |
01/20/2005 | WO2005005404A1 Cyclic fluorine compounds, polymerizable fluoromonomers, fluoropolymers, and resist materials containing the fluoropolymers and method for pattern formation |
01/20/2005 | WO2005005403A2 Process for preparation of oxetan-2-ones |
01/20/2005 | US20050014977 Process for the carbonylation of epoxides |
01/19/2005 | EP1497276A1 Conversion of taxane molecules |
01/19/2005 | EP1497275A1 Selective acylation of secondary hydroxyl groups |
01/19/2005 | EP1496896A1 Inhibitors of akt activity |
01/19/2005 | CN1568178A Injectable composition of paclitaxel |
01/19/2005 | CN1566106A Paclitaxel extraction using hazelnut |
01/18/2005 | US6844174 Preparing orlistat precursor from genetically engineered streptomyces; antidiabetic/hypotensive agents; insulin resistance |
01/18/2005 | CA2158458C Taxanes prepared by beta-lactams and ammonium alkoxides |
01/13/2005 | US20050009920 Taxol enhancer compounds |
01/13/2005 | US20050009783 Adjust solubility; dissolving taxol and cyclodextrin compound in ethanol; stirring; heating |
01/13/2005 | US20050009706 Herbicides; plant safening agents |
01/12/2005 | EP1495011A1 A semi-synthetic process for the preparation of n debenzoylpaclitaxel |
01/12/2005 | CN1184322C Method for mass production of taxinol by utilizing batch or semi-continuous culture |
01/12/2005 | CN1184219C Taxusane phoshponic oxygen methyl ether derivant |
01/05/2005 | CN1560042A Process for high efficient separating high pureness taxiol half sythesizing precursor |
01/04/2005 | US6838569 Process for preparation of paclitaxel trihydrate and docetaxel trihydrate |
01/04/2005 | CA2255637C Conjugates of cis-docosahexaenoic acid and paclitaxel |
12/30/2004 | US20040266859 oxidizing 7-triethylsilyl-13-ketobaccatin III to give 7-triethylsilyl-13-keto-14-hydroxy-baccatin III; carbonation of the 1 and 14 hydroxyls to give 14 beta -Hydroxy-7-TES-13-keto-baccatin III-1,14-carbonate; and reduction of the ketone at the 13-position and cleavage of the protective group |
12/29/2004 | EP1490348A1 Labelled taxanes |
12/29/2004 | CN1182126C Process for preparing high purity taxol by column bromating method |
12/29/2004 | CN1182094C Tubular chlorine alcoholating reactor without inner part and with chloride dissolved gradually |
12/29/2004 | CN1181915C Catalyst utilized for preparing propylene oxide in one-step oxidation of propylene gas phase and its preparation method |
12/28/2004 | US6835746 Taxoid anti-tumor agents and pharmaceutical compositions thereof |
12/22/2004 | CN1556799A Liquid crystalline oxetane compound, polymerizable liquid crystalline composition, method for producing liquid crystal film, optical film, and liquid crystal display |
12/22/2004 | CN1181066C Taxol separating and purifying process from taxad plant cell culture liquid flucculate |
12/16/2004 | US20040252171 Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method |
12/15/2004 | EP1486526A1 Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method |
12/15/2004 | CN1179955C Methodfor the preparation of taxol and its derivatives |
12/14/2004 | US6831180 Substituted tertiary carboxylic oxacycloalkane acids, used to prepare anhydro-homo-harringtonic acids by semi-synthesis; hydroxyl function of a cephalotaxane is esterified with a 2-carboxyl-2-alkyl-1-oxacycloalkane claimed intermediate; (indexing from 7169774 added) |
12/09/2004 | WO2004106314A1 Process for producing oxetane ring-containing biphenyl compound |
12/09/2004 | US20040248969 Process for the preparation of 4, 10 beta- diacetoxy-2 alpha-benzoyloxy-5 beta, 20-epoxy-1, 13 alpha-dihydroxy-9-oxo-19-norcyclopropa [g] tax-11-ene |
12/08/2004 | CN1553895A Taxol enhancer compounds |
12/07/2004 | US6828445 Process for the preparation of baccatin III derivatives |
12/02/2004 | US20040242674 For example, (2'R,3'R)-13-[N-benzoyl-3-(2-furyl)-2-methyl-isoserinoyl]-baccatin III, (2'R,3'R)-13-[N-t-butoxycarbonyl-3-(2-furyl)-2-methyl-isoserinoyl]-baccatin III; antitumor activity against cancer cells of the breast, lung, ovary, colon, prostate, kidney, pancreas |
11/30/2004 | US6825365 Intermediates for the hemisynthesis of taxanes and preparation processes therefor |
11/30/2004 | US6825316 Amorphous polyether glycols based on bis-substituted oxetane and tetrahydrofuran monomers |
11/30/2004 | US6825166 Molecular conjugates for use in treatment of cancer |
11/25/2004 | WO2004101542A1 Oxetane compounds containing cinnamyl functionality |
11/25/2004 | WO2004101541A1 Oxetane compounds containing styrenic functionality |
11/25/2004 | WO2004068930A3 Method and composition for preparing a compound using a benzolating agent essentially free of ring chlorination |
11/24/2004 | EP1478634A1 Furanone derivatives |
11/24/2004 | CN1548426A Prepn of polyene taxol trihydrate |
11/24/2004 | CN1176916C Semi-synthetic taxanes with antitumor and antiangiogenetic activities |
11/24/2004 | CN1176914C Intermediate for preparing 10-deacetylation baccatin III and 10-deacetylation-14 beta hydroxy baccatin III derivatives |
11/24/2004 | CN1176749C Formula and prepn process for epoxidating propylene to prepare epoxy propane catalyst in oxy-hydrogen atmosphere |
11/18/2004 | WO2004099167A1 The process for the preparation of docetaxel trihydrate |
11/17/2004 | CN1546479A Method and device for epoxidation of propylene using plasma of hydrogen and oxygen |
11/16/2004 | US6818789 Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one |
11/11/2004 | WO2004096786A1 Fluorinated cyclic compound, polymerizable fluoromonomer, fluoropolymer, resist material comprising the same, and method of forming pattern with the same |
11/11/2004 | US20040225081 Oxetane compounds containing cinnamyl functionality |
11/11/2004 | US20040225071 3-isopropenyl-a,a-dimethyl-benzylcarbamate ethyl (or methyl) oxetane; oxetane functionality is homopolymerizable in reactions that undergo cationic or anionic ring opening; styrenic is polymerizable with compounds such as electron acceptors |
11/11/2004 | US20040225009 For orally administered antitumor agents |
11/10/2004 | EP1417193A4 Efficient process for the production of 10-dab iii by selective hydrazinolysis of various taxanes |
11/10/2004 | EP1261657B1 Poly(3-cyclopropyl-3-hydroxypropionate) and processes for its preparation and derivatives thereof |
11/10/2004 | EP1137690B1 Peg-based macromonomers, chemically inert polymers prepared therefrom and the use of these polymers for organic synthesis and enzyme reactions |
11/10/2004 | CN1545555A Enzymatic resolution of t-butyl taxane derivatives |
11/10/2004 | CN1174748C New use of docetaxel for treating hepatoma |
11/09/2004 | US6815462 Anticarcinogenic, viricidal, and fungicidal agents; water solubility |
11/04/2004 | US20040220256 Formed as enantiomers of cis-beta-phenylglycidic acid/beta-phenylisoserine react with nitrile compound via ritter reaction |
11/03/2004 | EP1472255A1 Aza-arylpiperazines |
11/02/2004 | US6812356 Conversion 9-dihydro-13-acetylbaccatin III into 10-deacetylbaccatin III |
11/02/2004 | CA2153903C Process for the preparation of 10-desacetoxybaccatin iii |
10/28/2004 | WO2004092151A1 METHOD FOR PRODUCTION OF 4,10β-DIACETOXY-2$G(A)-BENZOYLOXY-5$G(B),20-EPOXY-1,13$G(A)-DIHYDROXY-9-OXO-19-NORCYCLOPROPA[G]TAX-11-ENE |
10/27/2004 | EP1470117A1 Methylenelactone synthesis in supercritical fluids |
10/27/2004 | EP1470116A2 Preparation of orlistat and orlistat crystalline forms |
10/27/2004 | EP0960108B1 Matrix metalloproteinase inhibitors |
10/27/2004 | CN1539831A Taxad alkyl derivative and its prepn. process |
10/27/2004 | CN1172925C Process for coproducing high purity taxol cephalomtanine, and 10-deacetyl Bakating III |
10/27/2004 | CN1172924C Alkyl olefine ketene dimer production method |
10/26/2004 | CA2120811C Improved process for manufacturing l-(-)-carnitine from waste products having opposite configuration |
10/21/2004 | WO2004089923A1 Carbonylation of epoxides |
10/21/2004 | US20040210030 hydroxylation of 3-cyclopropylacrylic acid to form 3-cyclopropyl-3-hydroxy-propionic acid; heating 3-cyclopropyl- beta -propiolactone to form vinylcyclopropane; depolymerization of poly(3-cyclopropyl-3-hydroxypropionate) to form alkali or alkaline salts of 3-cyclopropylacrylic acid |
10/21/2004 | US20040206933 Mesogenic compound with carbon, oxygen and sulfur liquid crystalsswitches |
10/20/2004 | CN1538963A Etticient process for production of 10-DAB III by selective hydrazinolysis of various taxanes |
10/20/2004 | CN1538841A C-2' methylated derivatives of paclitaxel for use as antitumour agents |
10/20/2004 | CN1537838A Method for synthesis of taxanes |
10/14/2004 | US20040204502 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
10/14/2004 | US20040204479 Injectable composition |
10/13/2004 | EP1466607A1 Compositions for the treatment of primary and metastatic neoplastic diseases using arsenic compounds in combination with all-trans retinoic acid |
10/13/2004 | EP1465661A1 Cancer treatment |
10/07/2004 | WO2004033442A3 Novel taxanes and methods related to use and preparation thereof |
10/07/2004 | US20040198814 prevention , therapy of cardiovascular disorders, dyslipidemias, glucose metabolism, hypoglycemic agents; reduce fat concentration in meat; reduce cholesterol concentration in eggs |
10/07/2004 | US20040197421 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
10/07/2004 | US20040197420 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
10/06/2004 | CN1534032A Method of high effect preparing rhoxadunol |
10/06/2004 | CN1534031A Catalytic distillation method of olefine direct epoxidation |
10/05/2004 | US6800660 Bis(thio-hydrazide amide) compounds; anticancer agents |
09/30/2004 | WO2004083176A2 Purification of taxanes and taxane mixtures using polyethyleneimine-bonded resins |
09/30/2004 | US20040192944 14-Hydrido-9beta-hydroxytetracyclic taxanes |
09/30/2004 | US20040192771 Cerdiovascular disorders; antilipemic agents; alzheimer's disease; anticancer agents; sepsis; thrombosis; hypotensive agents; kidney diseases; antiinflammatory agents |
09/30/2004 | CA2733837A1 Purification of taxanes and taxane mixtures using polyethyleneimine-bonded resins |
09/29/2004 | EP1461315A2 Catalytic carbonylation of three and four membered heterocycles |
09/29/2004 | EP1461029A1 Taxane based compositions and methods of use |